Correlation Between Connect Biopharma and Inventiva

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Inventiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Inventiva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Inventiva Sa, you can compare the effects of market volatilities on Connect Biopharma and Inventiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Inventiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Inventiva.

Diversification Opportunities for Connect Biopharma and Inventiva

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Connect and Inventiva is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Inventiva Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inventiva Sa and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Inventiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inventiva Sa has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Inventiva go up and down completely randomly.

Pair Corralation between Connect Biopharma and Inventiva

Given the investment horizon of 90 days Connect Biopharma Holdings is expected to under-perform the Inventiva. In addition to that, Connect Biopharma is 2.29 times more volatile than Inventiva Sa. It trades about -0.23 of its total potential returns per unit of risk. Inventiva Sa is currently generating about -0.02 per unit of volatility. If you would invest  271.00  in Inventiva Sa on August 28, 2024 and sell it today you would lose (4.00) from holding Inventiva Sa or give up 1.48% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Connect Biopharma Holdings  vs.  Inventiva Sa

 Performance 
       Timeline  
Connect Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Connect Biopharma Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Connect Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Inventiva Sa 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Inventiva Sa are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Inventiva sustained solid returns over the last few months and may actually be approaching a breakup point.

Connect Biopharma and Inventiva Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Connect Biopharma and Inventiva

The main advantage of trading using opposite Connect Biopharma and Inventiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Inventiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will offset losses from the drop in Inventiva's long position.
The idea behind Connect Biopharma Holdings and Inventiva Sa pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges